ANTI-POLYETHYLENE GLYCOL ANTIBODY

This adverse event was reported 2 times

These drugs are most commonly taken by patients reporting ANTI-POLYETHYLENE GLYCOL ANTIBODY:

# Drug Count
0 ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT 2
1 ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED-AUCL 1
See all common drugs associated with ANTI-POLYETHYLENE GLYCOL ANTIBODY

ANTI-POLYETHYLENE GLYCOL ANTIBODY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT 2 0.0035
1 ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED-AUCL 1 0.0011
See all drugs enriched for association with ANTI-POLYETHYLENE GLYCOL ANTIBODY

These drug classes are most commonly taken by patients reporting ANTI-POLYETHYLENE GLYCOL ANTIBODY:

# Drug class Count
See all common drug classes associated with ANTI-POLYETHYLENE GLYCOL ANTIBODY

ANTI-POLYETHYLENE GLYCOL ANTIBODY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
See all drug classes enriched for association with ANTI-POLYETHYLENE GLYCOL ANTIBODY